CCHFVaccine

• Research type

  Research Study

• Full title

  Crimean--Congo Haemorrhagic Fever vaccine: CCHFVaccine

• IRAS ID

  244268

• Contact name

  Stuart Dowall

• Contact email

  stuart.dowall@phe.gov.uk

• Sponsor organisation

  Public Health England

• Duration of Study in the UK

  3 years, 11 months, 31 days

• Research summary

  Crimean-Congo Haemorrhagic fever (CCHF) virus is a neglected emerging pathogen, which causes widespread and fatal epidemics in humans. There are no widely approved vaccines against CCHF virus.

  As part of an EU-funded project (CCHFVaccine), there is a work package on identification the immune signature of CCHF patients. The results will inform CCHF vaccine development and help to answer questions about what responses are associated with difference severities of diseases and protection against different lineages of virus strains.

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  18/EE/0098

• Date of REC Opinion

  29 Mar 2018

• REC opinion

  Unfavourable Opinion